Tracking baby health: does a migraine drug affect pregnancy?
NCT ID NCT05046613
Summary
This study aims to understand if the migraine medication rimegepant is safe during pregnancy. It will follow pregnant women with migraines, some who take the drug and some who do not, to track the health of both mother and baby for up to a year after birth. The goal is to collect safety information, not to provide treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Evidera, a PPD business unit
RECRUITINGWilmington, North Carolina, 28401, United States
Conditions
Explore the condition pages connected to this study.